Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Interest with Marathon

<< Previous

Bullboard Posts

Next >>

Comment by PWIB123on Sep 26, 2024 8:06pm

73 Views

Post# 36243285

RE:RE:Interest with Marathon

Since Marathon played both sides of the transaction, they need to bring their connections to the table and make something happen to benefit the ridiculous amount of warrants they required to negotiate the loan terms.

SPCEO1 wrote: Lower SOFR rates will help but it is minimal at this point. They really need to refinance this debt but can only refinance the first $37 million now - $37 million because they likely have ade 3 roughly $1 million payments already (assuming they don't want to pay a "make whole" penalty to Marathon on the other $20 million)
juniper88 wrote: This is a question for posters like Palinc who know about this financing a lot more than I do.

The 50 basis point cut by the Feb, does it have an impact on the interest rate Thera pays Marathon? I thought it was a variable rate. If yes, how much would thera be saving per quarter?